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To determine whether avian bornaviruses (ABVs) were 
a factor in proventricular dilatation disease (PDD), we used 
immunohistochemistry, reverse transcription–PCR, and 
nucleotide sequence analysis to examine paraffin wax–
embedded or frozen tissue samples of 31 psittacine birds 
with this disease. PDD is a fatal disease of psittacine birds 
associated with nonsuppurative encephalitis and ganglion-
euritis of the upper intestinal tract. Tissue samples had been 
collected from 1999 through 2008 in Austria, Switzerland, 
Hungary, and Australia. Immunohistochemical demonstra-
tion of viral antigen within the brain and vegetative nerve 
system of the gastrointestinal tract provides strong evi-
dence for a causative role of ABVs in this condition. Partial 
sequences of nucleoprotein (p40) and matrix protein (gp18) 
genes showed that virus in most of our cases belonged to 
the ABV-2 and ABV-4 groups among the 5 genogroups de-
scribed so far. Viral sequences of 2 birds did not match any 
of the described sequences and clustered together in a new 
branch termed ABV-6. 
Proventricular dilatation disease (PDD), a serious and frequent disease of predominantly psittacine birds, was 
reported for the first time in the late 1970s and early 1980s 
in the United States, in Germany, and in Switzerland (1,2). 
PDD affects >50 species of the order Psittaciformes, and 
single cases of a clinically and morphologically largely 
identical disease have also been found in nonpsittacine spe-
cies (3,4). The disease is characterized by nonsuppurative 
ganglioneuritis of the vegetative nerve plexuses of the crop, 
proventriculus, gizzard, and duodenum. In most cases, PDD 
is accompanied by nonsuppurative encephalomyelitis, and 
inflammation has also been noted in the peripheral nerves 
(5), myocardium (1,6,7), and adrenal glands (7).
Although a possible viral cause has been considered 
since the disease was recognized (1,2), and electron mi-
croscopic examination of affected tissues showed struc-
tures suggestive of viral particles, no convincing evidence 
for infection with a specific virus has been produced in 
the past 30 years. Recently, however, Kistler et al. (8) and 
Honkavuori et al. (9) provided evidence that PDD is asso-
ciated with the presence of novel virus species within the 
family Bornaviridae, provisionally termed avian bornavi-
rus (ABV). Using advanced molecular genetic technolo-
gies, they found sequences of at least 5 genetic subgroups 
of ABV in clinical specimens from most birds with PDD, 
but in none of the controls. These outstanding pioneer 
achievements have opened the doors to further research 
into the epizootiology, pathogenesis, and prevention of 
the disease.
In this study, we found ABVs within tissue lesions 
consistent with PDD by using immunohistochemical (IHC) 
testing, and we examined the distribution pattern of the 
ABV genotypes in various parts of the world. In addition, 
we describe tools for detecting viral signatures in archived 
paraffin wax–embedded tissue samples that are useful for 
retrospective studies.
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Methods
Tissue Samples
For this study, we had access to paraffin wax–embedded 
tissue samples from 25 psittacine birds (20 species) from 
Austria (N = 13), Switzerland (N = 11), and Australia (N 
= 1), which were obtained for pathologic examination from 
1999 through 2007 (online Appendix Table, available from 
www.cdc.gov/EID/content/15/9/1453-appT.htm). Each of 
these birds had received a diagnosis of PDD from the results 
of clinical, pathoanatomical, or pathohistologic examina-
tion. Samples from the brain and, if available, from the crop, 
proventriculus, and gizzard of all birds (except the bird from 
Australia) were used for IHC analysis and reverse transcrip-
tion–PCR (RT-PCR). From the 4 birds with the most abun-
dant immunostaining in these organs, other tissues, such as 
heart (n = 3), lung (n = 4), liver (n = 3), kidney (n = 3), or 
skin (n = 2) also underwent IHC testing. 
In addition, frozen samples of the brain and proven-
triculus of 6 psittacine birds from Switzerland (n = 4) and 
Hungary (n = 2), also with clinical, pathoanatomical, and 
pathohistologic diagnosis of PDD, were used for investiga-
tion by RT-PCR only. Paraffin wax–embedded tissue sam-
ples of brain from 5 psittacine birds with diagnoses other 
than PDD were used as negative controls.
IHC Testing
Sections (4 µm) were cut from tissue blocks, placed on 
positively charged glass slides (Menzel Gläser, Braunsch-
weig, Germany), and subjected to staining by IHC with 3 
anti–Borna disease virus (BDV) antibodies: 2 monoclonal 
antibodies directed against the N protein of BDV (Bo18: 
provided by S. Herzog, 38/17C1: provided by L. Stitz), and 
1 polyclonal antibody, directed against the phosphoprotein 
of BDV (provided by W.I. Lipkin). Selected slides of brain 
tissue were also stained with a polyclonal antibody for iden-
tification of astrocytes (anti–glial fibrillary acidic protein 
[GFAP], Dako, Glostrup, Denmark). After deparaffination 
and rehydration, antigen retrieval (except for GFAP) was 
performed by heating the slides in citrate buffer (pH 6.0) 
in a microwave oven. Endogenous peroxidase activity was 
blocked with 0.3% H2O2 in methanol for 30 min. Sections 
were then incubated with 1:10 diluted normal goat serum 
(Vector Laboratories, Burlingame, CA, USA) for 60 min, 
directly followed by an overnight incubation with the anti-
bodies mentioned above at 4°C (dilutions: Bo 18: 1:2,000; 
38/17C1 and antiphoshoprotein: 1:2,500, anti-GFAP: 
1:1,000). After being washed in phosphate-buffered saline, 
the tissues were incubated with biotinylated antimouse or 
antirabbit immunoglobulin G (Vector Laboratories, di-
lution 1:400) for 30 min, followed by staining using the 
Vectastain ABC Kit (Vector Laboratories) for 60 min. The 
reaction was visualized by using a 3,3′ diaminobenzidine 
Substrate Kit for Peroxidase (Vector Laboratories). After 
counterstaining with hemalum and dehydrating were car-
ried out, the slides were placed under coverslips with Neo-
mount (VWR, Vienna, Austria). Brain sections of a BDV-
infected horse and a psittacine bird with PDD in which the 
diagnosis ABV infection had been proven by sequencing 
of an RT-PCR amplification product were used as positive 
controls. Brain sections of psittacines with diagnoses other 
than PDD were used as negative controls.
Nucleic Acid Extraction and RT-PCR
Viral RNA was extracted from 10-µm sections of par-
affin wax–embedded psittacine tissue samples. Pools of 3 
to 5 sections of each block were processed. The origin of 
the samples is indicated in the online Appendix Table. The 
tissue sections were deparaffinized by incubation with 1 
mL xylene for 20 min at 37°C, followed by pelleting the 
tissues by centrifugation at 16,000 × g for 5 min at room 
temperature. Xylene was removed, and the pellets were re-
suspended in 1 mL RNase-free ethanol for 5 min at room 
temperature. The samples were centrifuged again at 16,000 
× g for 5 min at room temperature, and the ethanol treat-
ment was repeated. After centrifugation, the ethanol was 
removed, and the pellets were air-dried. Thereafter, the tis-
sue samples were resuspended in 250 µL ATL tissue lysis 
buffer (QIAGEN, Hilden, Germany) and 25 µL Proteinase 
K (QIAGEN) was added. Samples were digested with pro-
teinase for 16 h at 55°C, followed by an enzyme-inactiva-
tion step for 8 min at 95°C. Viral RNA was extracted from 
140 µL of the tissue lysates by using the QIAamp Viral 
RNA Mini Kit (QIAGEN) according to the manufacturer’s 
recommendations.
BDV-specific nucleic acid sequences deposited in 
GenBank database, including the 5 ABV genotypes de-
scribed to date (8), were aligned and analyzed for con-
served genomic sections. Bornavirus-specific univer-
sal oligonucleotide primer pairs were designed, which 
annealed to putative N protein (forward primer 5′-
CATGAGGCTATWGATTGGATTA-3′ and reverse 
primer 5′-TAGCCNGCCMKTGTWGGRTTYT-3′) and 
to matrix (M) protein gene regions (forward primer 5′-
CAAGGTAATYGTYCCTGGATGG-3′ and reverse primer 
5′-ACCAATGTTCCGAAGMCGAWAY-3′) of ABVs, 
respectively. These primers corresponded to nt positions 
632–653 and 999–1020 (N gene) and 1908–1929 and 
2238–2259 (M gene) of the complete genome of ABV 
strain “bil,” GenBank accession no. EU781967 (8). Be-
cause mostly paraffin wax–embedded tissue samples were 
used as sample material, primers for the amplification of 
relatively short PCR products were designed (389 and 352 
bp, respectively), to reduce the chance of false-negative re-
actions due to the RNA fragmentation effect of the formal-
dehyde fixation.
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ABV RNAs were reverse-transcribed and amplified 
with a continuous RT-PCR method by using a One Step 
RT-PCR kit (QIAGEN) according to the manufacturer’s 
instructions. Primers were used at final concentrations of 
0.8 µmol/L. Amplifications were performed in a GeneAmp 
PCR System 2700 thermocycler (Applied Biosystems, Fos-
ter City, CA, USA). The temperature profile for the RT-
PCR was as follows: 30 min at 50°C, 15 min at 95°C, 45× 
(30 s at 94°C, 30 s at 50°C, and 30 s at 72°C), and 7 min 
at 72°C. RNA extracts from psittacine organs without indi-
cation of PDD served as negative controls. PCR products 
were subjected to electrophoresis in 1.5% Tris acetate–ED-
TA agarose gels and stained with ethidium bromide.
Sequencing and Sequence Analysis
PCR products were purified with the Quantum Prep 
PCR Kleen Spin Columns (Bio-Rad, Hercules, CA, USA) 
according to the manufacturer’s protocol. Fluorescence-
based direct sequencing of the amplicons was performed 
in both directions by using the ABI PRISM Big Dye Ter-
minator Cycle Sequencing Ready Reaction Kit (Applied 
Biosystems) (13). Nucleotide sequences were identified 
by the Basic Local Alignment Search Tool (BLAST [14]) 
and were aligned by using the Align Plus program, version 
4.1 (Scientific and Educational Software, Cary, NC, USA). 
Multiple alignments for phylogenetic analyses were created 
by using the ClustalX program (15). Phylogenetic analyses 
were conducted by the neighbor-joining algorithm. Boot-
strap resampling analyses of the phylogenetic trees were 
performed on 1,000 replicates. Trees were drawn with the 
help of the TreeView 1.6.6 software (Scientific and Edu-
cational Software). Besides the nucleotide sequences ob-
tained in this study, all ABV sequences of the investigated 
genomic regions, which had been deposited in the GenBank 
database by other authors (8,9), were also included in the 
sequence alignments and phylogenetic analyses. The ABV 
sequences described in this article were submitted to Gen-
Bank database under accession nos. FJ794724–FJ794754 
(online Appendix Table).
Results
IHC Testing
The monoclonal antibodies used (Bo18, 38/17C1), 
which produced clear specific immunoreactivity in the 
BDV-infected equine brain control section, showed nega-
tive results on the avian control brain and tissues of PDD 
birds. The polyclonal antibody directed against recombi-
nant BDV phosphoprotein, however, showed positive re-
sults (Figures 1, 2). All PDD samples examined (N = 24) 
showed immunoreactivity in at least 1 brain sample. Other 
positive tissues were the proventriculus, gizzard, crop, 
small intestine, heart, and lung. In the brain, positive re-
sults were randomly distributed, without predilection to 
specific neuroanatomic locations. The quantity of positive 
cells ranged from single cells in the entire section to large 
numbers of positive cells, which in certain brain areas ac-
counted for up to one third of all cells. The positive cells 
were found more frequently in the gray matter, but were 
also found in the white matter. Neurons were consistently 
found to be positive (Figure 1, panels C–F). Their staining 
pattern was variable and included positive nuclei and nega-
tive cytoplasm, positive nuclei and cytoplasm, or negative 
nuclei and positive cytoplasm.
In several cases, a peculiar nuclear staining pattern 
occurred, with 1 or several distinctly stained spheroid in-
tranuclear bodies, either present as a sole nuclear immu-
noreaction or as a reaction in context with diffuse nuclear 
or cytoplasmic staining, or as both. Occasionally, neuronal 
processes in gray and white matter were distinctly labeled 
(Figure 1, panel G). In addition, astrocytes occasionally 
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Figure 1. Avian bornavirus protein demonstrated by 
immunohistochemical testing in the central nervous system of 
birds with proventricular dilatation disease (PDD). A) within nuclei, 
cytoplasm and dendrites of several Purkinje cells of the cerebellum, 
bar = 50 µm; B) negative control: no immunoreactivity of Purkinje 
cells in a PDD-negative bird, bar = 50 µm; C–F), different 
phenotypes of positive neurons: C) within neurons, viral protein is 
expressed within intranuclear inclusion bodies; D) diffusely within 
the nucleus accompanied by faint cytoplasmic staining; E) both, 
within the nucleus and cytoplasm, with more intense staining of 
intranuclear inclusion bodies; F) exclusively within the cytoplasm 
and the nucleus spared, bar = 12.5 µm; G) within an axon in the 
white matter of the medulla oblongata, bar = 25 µm; H, negative 
control: no immunoreactivity of a cerebral neuron in a PDD-negative 
bird, bar = 12.5 µm.
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showed positive results, with several specifically stained in-
tranuclear bodies. Identity of astrocytes was confirmed by 
IHC demonstration of GFAP in the cytoplasm of the same 
cells in a directly adjacent serial section. Some areas also 
displayed more or less intense immunoreactivity of the neu-
ropil. There was no immunostaining in the negative con-
trols (Figure 1, panels B, H). Most samples (n = 16) showed 
mild-to-severe nonsuppurative inflammation in the brain 
sections examined, but several samples (n = 8) did not show 
inflammatory infiltrates. No direct correlation was found 
between location of inflammation and presence of viral an-
tigen. In the proventriculus, crop, gizzard, and small intes-
tine, intramural or subserous nerve plexus and ganglia had 
positive results. Nuclei and cell bodies of enteral ganglia as 
well as nerve fibers had distinctly positive results (Figure 
2, panels A, B). All examined enteric vegetative ganglia or 
nerves showed mild-to-severe inflammatory infiltration. In 
some cases, smooth muscle fibers also showed strong im-
munoreactivity (Figure 2, panel C). In the heart, vegetative 
nerve fibers, large modified muscle fibers of the conduction 
system (Figure 2, panel D), and foci of normal heart muscle 
fibers (Figure 2, panel E) showed positive results. In the 
lung, some interstitial nerve fibers also showed positive re-
sults. No unequivocal identification of positive staining was 
found in other organs, such as liver, kidney, or skin.
RT-PCR and Nucleotide Sequence Analysis
Amplification products of previously calculated sizes 
were generated by the RT-PCR assays. No amplification 
products were obtained from PDD-negative psittacine 
samples. In several cases, brain and proventriculus from 
the same animal were simultaneously tested. In general, 
brain samples gave more frequent and more intensive re-
sults; however, in some cases, proventriculi showed posi-
tive results, and brains showed negative results. The results 
of IHC and RT-PCR investigations were mainly consis-
tent. However, in the case of 2 samples from Austria with 
IHC-positive results, the results of repeated RT-PCRs were 
always negative (samples 801–01 and 1688–04; online 
Appendix Table). All samples were tested with N–and M 
gene–specific primer pairs. The M protein gene regions of 
all 29 samples were successfully amplified, but at the N 
coding region, only 22 samples showed unambiguously 
positive reactions. The nucleotide sequences of the amplifi-
cation products were identified in at least 2 independent se-
quencing reactions. In several electrophorograms, overlap-
ping peaks were detected at certain loci, even after repeated 
processing (repeated nucleic acid extraction, RT-PCR, and 
sequencing) of the samples. These variable loci were of-
ten in common in different samples, and in a few cases, 
unambiguous consensus sequences could not be obtained 
because of this fact.
Amplification products from brain and proventriculus 
of the same birds were sequenced in 12 samples. Notably, 
in 2 samples, nucleotide sequences obtained from brain and 
proventriculus of the same parrot differed in the N coding 
region by a few nucleotides, although they were identical in 
the M gene region. In all other cases, however, the sequenc-
es obtained from brain and proventriculus of the same birds 
were identical. The partial N gene sequence (between nt 
positions 654 and 998, referred to the complete ABV ge-
nome record EU781967) of 22 samples, and the partial M 
gene sequence (between nt positions 1930 and 2237) of 29 
samples were determined. The sequences shared the high-
est identity rates with ABV sequences after BLAST search 
against the GenBank database. The nucleotide identity 
rates of the newly determined and the GenBank sequences 
varied between 71% and 100% in the nucleoprotein gene 
region, and between 68% and 100% in the M protein gene 
region. The sequences from 14 samples showed the highest 
similarity rates (92% to 100%) to ABV-2 sequences, and 
13 samples were most similar (94% to 100%) to ABV-4 
sequences. The M gene sequences of the samples 281–01 
and H03–2080, however, were only 71% to 82% identi-
cal to any other known bornavirus sequence. From these 
samples, amplification products were not obtained with the 
N gene–specific primer pair.
Phylogenetic trees (Figures 3, 4), based on the N and 
M protein gene regions, showed similar structures. The se-
quences did not exhibit any clustering according to either 
the collection year, country of origin, or host species. ABV 
sequences from different countries in Europe and from 
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Figure 2. Avian bornavirus protein demonstrated by immuno-
histochemical testing in extracerebral locations. A) within neurons 
of proventricular intramural vegetative ganglia with inflammatory 
infiltration, bar = 25 µm; B) within nerve fibers of the myenteric 
plexus of gizzard, bar = 25 µm; C) within smooth muscle fibers of 
the proventricular wall, bar = 50 µm; D) within a modified muscle 
fiber of the conductive system of the heart, bar = 50 µm; E) within 
myocardiocytes, bar = 25 µm.
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Australia were similar, or even homologous to each other. 
Moreover, the newly determined sequences proved to be 
frequently similar or homologous to GenBank sequences 
derived from samples collected in the United States and in 
Israel. The newly identified sequences clustered within the 
same main branches in the N and M gene trees. Two similar 
M protein gene sequences (281–01 and H03–2080), how-
ever, exhibited low identity rates to all other sequences and 
formed a distinct branch in the phylogenetic tree, which 
was clearly separated from all other groups of ABVs and 
mammalian bornaviruses. Consequently, we suggest that 
this unique cluster be accepted as a novel ABV genotype, 
designated ABV-6. The bootstrap analysis supported the 
main clustering of the consensus trees.
Discussion
The successful IHC demonstration of ABV antigens 
in birds with PDD by using a polyclonal serum against the 
phosphoprotein of BDV shows that, despite their diversity, 
ABVs and BDV share epitopes. Positive results for virus 
were found for neurons and nerve fibers of the brain, and in 
ganglia, nerve fibers, and smooth muscle fibers of the up-
per digestive tract as well as in myocytes and fibers of the 
conductive system of the heart.
Typical for the presence of bornaviruses is the loca-
tion of viral protein within distinct intranuclear inclusions 
(called Joest-Degen inclusion bodies in classic BD of neu-
rons, which have been shown to be sites of viral transcrip-
tion and translation (16,17). In the PDD samples analyzed 
here, such immunoreactive intranuclear bodies were consis-
tently found in brain neurons. In at least 2 studies, histolog-
ic pictures of celiac ganglia undoubtedly show intranuclear 
inclusion bodies, which strongly resemble the intranuclear 
inclusion bodies known from BD (2,18). PDD is character-
ized by an immunologic attack of infiltrating immune cells 
on the autonomous nervous system of the upper digestive 
tract. In classic BD, however, this phenomenon is not ob-
served. Here, inflammation remains confined to the central 
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 9, September 2009 1457 
Figure 3. Phylogram illustrating the genetic relationship among 
avian bornavirus (ABV) genotypes, based on a partial nucleoprotein 
gene region. Three representatives of Borna disease virus (BDV) 
were used as outgroups. Scale bar indicates genetic distance; the 
bootstrap support values are shown for the main nodes. ABVs are 
identified by GenBank accession number/country of origin/year of 
collection. Further details are shown in the online Appendix Table 
(available from www.cdc.gov/EID/content/15/9/1453-appT.htm). 
Nucleotide sequences determined in this study are highlighted in 
different colors according to their country of origin. The main ABV 
genogroups are indicated.
Figure 4. Phylogram illustrating the genetic relationship among 
avian bornavirus (ABV) genotypes, based on a partial matrix 
protein gene region. Three representatives of BDV were used as 
outgroups. Scale bar indicates genetic distance; the bootstrap 
support values are shown for the main nodes. ABVs are identified 
by GenBank accession number/country of origin/year of collection. 
Further details are shown in the online Appendix Table (available 
from www.cdc.gov/EID/content/15/9/1453-appT.htm). Nucleotide 
sequences determined in this study are highlighted in different colors 
according to their country of origin. The main ABV genogroups are 
indicated.
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nervous system, although centrifugal spread of virus into 
peripheral nerves and autonomic nerve fibers and ganglia 
has been shown in experimentally infected rats (19,20).
Some of the birds showed viral antigen in extraneural 
tissues, such as smooth or heart muscle fibers. These find-
ings are comparable to the situation in rats that were experi-
mentally infected as newborns, which are immunotolerant 
to the virus, or in animals in which artificial immunosup-
pression is induced. In the absence of an efficient immune 
response, these animals show that spread of infectious virus 
to several nonneural tissue cells, such as hepatocytes, tubu-
lar epithelial cells of the kidney, and myocytes of the in-
testine and heart (19,21,22). Whether birds with PDD have 
deficient humoral or cellular immune responses to ABVs 
remains to be shown.
BDV isolates from different mammal species exhibit a 
high level of nucleotide sequence conservation (23). Con-
trary to this finding, the nucleotide sequences of the so far 
detected ABVs show striking diversity. Kistler et al. (8) 
identified 5 distinct genetic groups of ABV sequences ob-
tained from psittacinae birds from the United States and 
from Israel. The genetic characterization of 28 ABVs from 
Europe and 1 ABV from Australia showed that most of the 
viruses belong to the second and the fourth genetic group of 
the above-mentioned classification. Two viruses, however, 
formed a separate genetic group, which showed a similar 
genetic distance to the other 5 ABV groups as the distance 
to the representatives of BDV. Therefore, we believe that 
the establishment of a sixth group, termed ABV-6, in the 
preliminary classification of ABVs, is justified.
Another noteworthy observation is that ABV se-
quences obtained from certain tissue samples showed 
single or multiple nucleotide polymorphisms. The consis-
tent results of repeated RT-PCRs and sequence determi-
nations indicate that the polymorphism is not related to 
the in vitro amplifications and sequence determinations, 
but that the original samples contain mixtures of ABV 
sequences. One plausible explanation is that those birds 
were simultaneously infected with at least 2 ABV geno-
types. Another possibility is that ABV exhibits quasispe-
cies character; however, this situation would be rather 
unusual when compared to the characteristics of BDV. 
The mammalian bornaviruses represented by BDV form a 
separate branch within the bornaviruses and reflect strong 
sequence conservation as well as geographic clustering 
independently from year of isolation and species (23,24). 
The strain No/98 is an exception within this group because 
it originates from a horse outside of disease-endemic re-
gions and possesses a higher sequence variation than the 
other mammalian bornaviruses, thereby being the closest 
relative to the ABVs thus far (12).
To this point, ABVs have been detected in at least 27 
psittacine species from 4 different continents. Phylogenetic 
analyses do not indicate species-specificity or geographic 
clustering of the different ABV genogroups. The 2 ABV-6 
genogroup sequences, which were detected in birds from 
Austria and Switzerland, are from geographically close ar-
eas; however, further investigations may show more wide-
spread distribution of viruses from this genogroup as well. 
The wide geographic spread of different virus genotypes is 
most likely strongly influenced by the worldwide trade of 
the host species. 
The diagnostic methods described in this article were 
found to be useful tools for the direct demonstration of viral 
RNA and antigens of different ABV genotypes in archived 
paraffin wax–embedded tissue samples as well as in fresh-
frozen tissue samples. Because of the observed nucleotide 
sequence diversity, molecular techniques also have certain 
limitations. Of the 29 investigated birds, 2 gave positive 
IHC results with the polyclonal BDV serum, but gave neg-
ative results in both RT-PCR assays. These samples might 
contain ABVs that are genetically different from those of 
genogroups 2, 4, and 6.
The results of this study, as do those of another study 
published during the review of this manuscript (25), show 
that birds from Europe with PDD are consistently infected 
with ABVs and that they display viral antigen in neural and 
extraneural tissues. Issues that remain to be resolved, how-
ever, are whether psittacine birds are also the natural res-
ervoir of these viruses or whether other species, in which 
disease probably does not develop upon infection, will be 
identified in the future. However, virus has not yet been 
detected in clinically healthy birds. The task of identifying 
natural reservoir hosts can be painstaking. For BDV, the 
search has been unsuccessful for decades, until Hilbe et al. 
suggested that a shrew species (Crocidura leucodon) may 
be a candidate for a natural reservoir host (26).
Acknowledgments
We are grateful to Peter Sandmeier, who submitted PDD-
affected birds for further investigations; and to W. Ian Lipkin, 
Lothar Stitz, and Sybille Herzog for the generous gifts of BDV-
specific antibodies. We also thank Helga Lussy, Christine Glatzer, 
and Karin Fragner for excellent technical assistance; and Klaus 
Bittermann for his help with the digital artwork.
This study was partially supported by the grant OTKA 
K67900. T B. is grantee of the “Bolyai János” postdoctoral fel-
lowship grant of the Hungarian Academy of Science.
Dr Weissenböck is an associate professor at the University 
of Veterinary Medicine, Vienna. His research interests include 
neuropathology, neurovirology, and pathology of infectious dis-
eases.
1458 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 9, September 2009
Proventricular Dilatation Disease in Birds
References
  1.  Gregory CR, Latimer KS, Niagro FD, Ritchie BW, Campagnoli RP, 
Norton TM, et al. A review of proventricular dilatation syndrome. J 
Assoc Avian Vet. 1994;8:69–75.
  2.  Mannl A, Gerlach H, Leipold R. Neuropathic gastric dilatation in 
psittaciformes. Avian Dis. 1987;31:214–21. DOI: 10.2307/1590799
  3.  Daoust PY, Julian RJ, Yason CV, Artsob H. Proventricular impaction 
associated with nonsuppurative encephalomyelitis and ganglioneu-
ritis in two Canada geese. J Wildl Dis. 1991;27:513–7.
  4.  Perpiñán D. Fernández-Bellon H, Lόpez C, Ramis A. Lymphoplas-
macytic myenteric, subepicardial, and pulmonary ganglioneuritis in 
four nonpsittacine birds. J Avian Med Surg. 2007;21:210–4. DOI: 
10.1647/1082-6742(2007)21[210:LMSAPG]2.0.CO;2
  5.  Berhane Y, Smith DA, Newman S, Taylor M, Nagy E, Binning-
ton B, et al. Peripheral neuritis in psittacine birds with proven-
tricular dilatation disease. Avian Pathol. 2001;30:563–70. DOI: 
10.1080/03079450120078770
  6.  Vice CA. Myocarditis as a component of psittacine proven-
tricular dilatation syndrome in a Patagonian conure. Avian Dis. 
1992;36:1117–9. DOI: 10.2307/1591587
  7.  Busche R, Frese K, Weingarten M. Zur Pathologie des Macaw Wast-
ing Syndroms. Verh-Ber Erkr Zoot. 1985;27:325–9.
  8.  Kistler AL, Gancz A, Clubb S, Skewes-Cox P, Fischer K, Sorber 
K, et al. Recovery of divergent avian bornaviruses from cases of 
proventricular dilatation disease: identification of a candidate etio-
logic agent. Virol J. 2008;5:88. DOI: 10.1186/1743-422X-5-88
  9.  Honkavuori KS, Shivaprasad HL, Williams BL, Quan PL, Hornig 
M, Street C, et al. Novel borna virus in psittacine birds with proven-
tricular dilatation disease. Emerg Infect Dis. 2008;14:1883–6. DOI: 
10.3201/eid1412.080984
10.  Doneley RJ, Miller RI, Fanning TE. Proventricular dilatation dis-
ease: an emerging exotic disease of parrots in Australia. Aust Vet J. 
2007;85:119–23. DOI: 10.1111/j.1751-0813.2007.00109.x
11.  Pleschka S, Staeheli P, Kolodziejek J, Richt JA, Nowotny N, 
Schwemmle M. Conservation of coding potential and terminal se-
quences in four different isolates of Borna disease virus. J Gen Virol. 
2001;82:2681–90.
12.  Nowotny N, Kolodziejek J, Jehle CO, Suchy A, Staeheli P, Schwem-
mle M. Isolation and characterization of a new subtype of Borna dis-
ease virus. J Virol. 2000;74:5655–8. DOI: 10.1128/JVI.74.12.5655-
5658.2000
13.  Grabensteiner E, Ritter W, Carter MJ, Davison S, Pechhacker H, 
Kolodziejek J, et al. Sacbrood virus of the honeybee (Apis mellif-
era): rapid identification and phylogenetic analysis using reverse 
transcription-PCR. Clin Diagn Lab Immunol. 2001;8:93–104.
14.  Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local 
alignment search tool. J Mol Biol. 1990;215:403–10.
15.  Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. 
The CLUSTAL X windows interface: flexible strategies for multiple 
sequence alignment aided by quality analysis tools. Nucleic Acids 
Res. 1997;25:4876–82. DOI: 10.1093/nar/25.24.4876
16.  Sasaki S, Ludwig H. In Borna disease virus infected rabbit neurons 
100 nm particle structures accumulate at areas of Joest-Degen inclu-
sion bodies. Zentralbl Veterinarmed B. 1993;40:291–7. 
17.  Malik TH, Kishi M, Lai PK. Characterization of the P protein-bind-
ing domain on the 10-kilodalton protein of Borna disease virus. J 
Virol. 2000;74:3413–7. DOI: 10.1128/JVI.74.7.3413-3417.2000
18.  Grimm F. Der klinische Fall Neuropathische Magendilatation eines 
Ara. Tierarztl Prax. 1991;19:111–2.
19.  Stitz L, Noske K, Planz O, Furrer E, Lipkin WI, Bilzer T. A func-
tional role for neutralizing antibodies in Borna disease: Influ-
ence on virus tropism outside the central nervous system. J Virol. 
1998;72:8884–92.
20.  Pfannkuche H, Konrath A, Buchholz I, Richt JA, Seeger J, Müller H, 
et al. Infection of the enteric nervous system by Borna disease virus 
(BDV) upregulates expression of calbindin D-28k. Vet Microbiol. 
2008;127:275–85. DOI: 10.1016/j.vetmic.2007.09.005
21.  Herzog S, Kompter C, Frese K, Rott R. Replication of Borna dis-
ease virus in rats: age-dependent differences in tissue distribution. 
Med Microbiol Immunol (Berl). 1984;173:171–7. DOI: 10.1007/
BF02122108 
22.  Stitz L, Schilken D, Frese K. Atypical dissemination of the highly 
neurotropic Borna disease virus during persistent infection in cy-
closporine A–treated, immunosuppressed rats. J Virol. 1991;65: 
457–60.
23.  Kolodziejek J, Dürrwald R, Herzog S, Ehrensperger F, Lussy H, No-
wotny N. Genetic clustering of Borna disease virus natural animal 
isolates, laboratory and vaccine strains strongly reflects their region-
al geographical origin. J Gen Virol. 2005;86:385–98. DOI: 10.1099/
vir.0.80587-0
24.  Dürrwald R, Kolodziejek J, Muluneh A, Herzog S, Nowotny N. Epi-
demiological pattern of classical Borna disease and regional genetic 
clustering of Borna disease viruses point towards the existence of to-
date unknown endemic reservoir host populations. Microbes Infect. 
2006;8:917–29. DOI: 10.1016/j.micinf.2005.08.013
25.  Rinder M, Ackermann A, Kempf H, Kaspers B, Korbel R, Staeheli 
P. Broad tissue and cell tropism of avian bornavirus in parrots with 
proventricular dilatation disease. J Virol. 2009;83:5401–7.
26.  Hilbe M, Herrsche R, Kolodziejek J, Nowotny N, Zlinszky K, 
Ehrensperger F. Shrews as reservoir hosts of Borna disease virus. 
Emerg Infect Dis. 2006;12:675–7.
Address for correspondence: Norbert Nowotny, Zoonoses and Emerging 
Infections Group, Clinical Virology, Department of Pathobiology, 
University of Veterinary Medicine Vienna, Veterinärplatz 1, A-1210 
Vienna, Austria; email: norbert.nowotny@vetmeduni.ac.at
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 9, September 2009 1459 
